1 min read
Add as a preferred source on Google

Purple Biotech Posts $0.51 Third-Quarter GAAP Loss Per Share

The company held $5.1 million in cash, cash equivalents and short-term deposits as of Sept. 30, 2026, with a projected runway through late 2027.

A blank banknote rests inside a clear glass dish / TokenPost.ai
A blank banknote rests inside a clear glass dish / TokenPost.ai

Purple Biotech posted a GAAP loss of $0.51 per share for the third quarter. The company held $5.1 million in cash, cash equivalents and short-term deposits as of Sept. 30, 2026.

Management’s current estimates and operating plan project that the funds will provide a runway through late 2027.

John Kim

John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.

Loading…